Chris Reddick, PhD

Dr. Chris Reddick is currently the Head of U.S. Health Equity with responsibility for developing and executing Takeda’s health equity strategy in the U.S. to address health disparities and inequities in communities and ensure broader patient access to Takeda’s medicines.  He is a medical scientist by training and has spent more than 20 years working in healthcare to advance health equity and access to quality healthcare. In addition to his work at Takeda driving health equity strategy, Chris has amassed a wealth of experience in community-based healthcare through his work with public health organizations, non-profits, and academic institutions to help strengthen healthcare systems in underserved communities around the world.